APASL 2026 Day 1 — What’s shaping hepatology right now?
From HEV insights to HBV biomarkers and AI-driven fibrosis prediction — key discussions are already setting the tone for clinical practice.
We’ve curated the most relevant highlights so you don’t miss what truly matters.
👉 Explore full updates on GastroAGI
#GastroAGI #APASL2026 #Hepatology #LiverDisease #HBV #HEV #MASLD #HCC #MedicalEducation #GIUpdates #MedEd #ClinicalInsights
Recurrent dysphagia after esophageal SEMS?
👉 Don’t assume tumor progression.
📸 X-ray: Stent migrated into stomach
💡 Most common cause: stent migration
🔧 Next step:
✔ Endoscopy
✔ Retrieval ± re-stenting (better fixation)
🎯 Restore swallowing, improve QOL
#EsophagealCancer #GI #Endoscopy #Oncology #Dysphagia #GastroAGI
GLP-1 vs bariatric endoscopy — no clear winner.
Meta-analysis (Obesity Surgery, Apr 2026): similar short-term weight loss, BMI reduction, and glycemic control.
Difference lies in safety:
GLP-1 → GI side effects
Endoscopy → procedural/device risks
Treatment should be individualized. Long-term data needed.
#GastroAGI #Obesity #GLP1 #BariatricEndoscopy #Type2Diabetes
Diffuse continuous colonic wall thickening with pancolitis pattern strongly suggests ulcerative colitis, especially when disease is continuous without skip lesions.
#GastroAGI #UlcerativeColitis #IBD #Gastroenterology #Radiology #CTScan #InflammatoryBowelDisease #GIeducation
🔬 Biopsy smart, not routine.
Knowing when to biopsy—and when not to— can change diagnosis, management, and outcomes in upper GI endoscopy.
From Barrett’s protocols to linitis plastica sampling—precision matters.
#GastroAGI #Endoscopy #UpperGI #Biopsy #Gastroenterology #GIEndoscopy #MedicalEducation
🎯 HCC treatment is evolving…
TACE + immunotherapy + targeted therapy shows stronger outcomes—but are we ready to change practice?
⚠️ Promising data, but guidelines still need phase III confirmation
#GastroAGI #HCC #LiverCancer #TACE #Immunotherapy #TargetedTherapy #Hepatology #Oncology #MedEd
CT chest shows a markedly dilated, fluid-filled oesophagus with smooth distal tapering and no obstructing mass—imaging features suggestive of achalasia.
Diagnosis confirmed on high-resolution manometry (Type II).
Patient underwent POEM, with dysphagia score improving
from 3 → 1.
📌 A nice example of radiology–manometry–endoscopy concordance and clinical response.
Nutrition is central in cirrhosis care. Malnutrition, sarcopenia, and frailty worsen transplant outcomes.
Early assessment, adequate calories, and high-quality protein prehabilitation preserve muscle and resilience. The waitlist is a window to intervene.
#Cirrhosis #Hepatology #TransplantMedicine #NutritionInCirrhosis #Sarcopenia #MedicalEducation #EvidenceBasedMedicine #GastroAGI
GastroAGI is an AI-powered knowledge platform for gastroenterology & hepatology—built for clinicians, trainees, and researchers.
Evidence-first answers from journals, guidelines, and conferences. No noise. No hallucinations. Just clarity.
#GastroAGI #Gastroenterology #Hepatology #MedicalAI #EvidenceBasedMedicine #MedEd #ClinicalPractice #GIResearch
miR147 protects gut mucosa by strengthening epithelial integrity and controlling inflammation.
Knockout → severe colitis, barrier loss, ↑ permeability.
miR147 targets Ndufa4 to maintain metabolic balance + type I IFN signaling.
Therapeutic potential in IBD & colorectal cancer.
GastroAGI